LUMINITA STUTZ: Open Payments
NPI 1043411739 · EVANSTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 14 payments from 11 companies in 2025. Trend: 2023 $513 · 2024 $657 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $148 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $20 |
Products named: Fabhalta, JYNARQUE, Kerendia, STRENSIQ, FARXIGA, SHINGRIX, JARDIANCE, TARPEYO.
Industry payments across IL — which companies pay providers there.
